自閉症スペクトラム障害治療薬の世界市場 2023-2027

自閉症スペクトラム障害治療薬市場は2022-2027年に7億7,265万米ドル、予測期間中のCAGRは7.2％で成長すると予測されます。

当レポートでは、自閉症スペクトラム障害治療薬市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。ASDの有病率の増加、官民パートナーシップの増加、自閉症スペクトラム障害に対する意識の高まりが市場を牽引しています。

本調査では、ASD治療における個別化医療への関心の高まりが、今後数年間の自閉症スペクトラム障害治療薬市場成長を牽引する主要因の1つであると特定しています。また、デジタル治療薬の使用増加やASDに対する酵素補充療法（ERT）の探求の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 自閉症スペクトラム障害治療薬の世界市場 2017-2021
• 流通チャネルセグメント分析 2017-2021
• タイプセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 小売薬局：市場規模と予測 2022-2027
• 病院薬局：市場規模と予測 2022-2027
• オンライン薬局：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 覚醒剤：市場規模と予測 2022-2027
• 選択的セロトニン再取り込み阻害剤：市場規模と予測 2022-2027
• 抗精神病薬：市場規模と予測 2022-2027
• 睡眠薬：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Bristol Myers Squibb Co.
• CureMark LLC
• F. Hoffmann La Roche Ltd.
• Jazz Pharmaceuticals Plc
• Les Laboratoires Servier SAS
• Neurim Pharmaceuticals Ltd.
• Novartis AG
• Oryzon Genomics SA
• Otsuka Holdings Co. Ltd.
• Q BioMed Inc.
• Scioto Biosciences Inc.
• Spectrum Pharmaceuticals Inc.
• Stalicla SA
• Yamo Pharmaceuticals LLC
• Zynerba Pharmaceuticals Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global autism spectrum disorder therapeutics market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by Distribution Channel ($ million)
• Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits48: Chart on Type - Market share 2022-2027 (%)
• Exhibits49: Data Table on Type - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Stimulants - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Stimulants - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Stimulants - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Stimulants - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Sleep medications - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Data Table on Sleep medications - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Chart on Sleep medications - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Sleep medications - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits72: Market opportunity by Type ($ million)
• Exhibits73: Data Table on Market opportunity by Type ($ million)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ million)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits117: Impact of drivers and challenges in 2022 and 2027
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: Bristol Myers Squibb Co. - Overview
• Exhibits124: Bristol Myers Squibb Co. - Product / Service
• Exhibits125: Bristol Myers Squibb Co. - Key news
• Exhibits126: Bristol Myers Squibb Co. - Key offerings
• Exhibits127: CureMark LLC - Overview
• Exhibits128: CureMark LLC - Product / Service
• Exhibits129: CureMark LLC - Key offerings
• Exhibits130: F. Hoffmann La Roche Ltd. - Overview
• Exhibits131: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits132: F. Hoffmann La Roche Ltd. - Key news
• Exhibits133: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits134: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits135: Jazz Pharmaceuticals Plc - Overview
• Exhibits136: Jazz Pharmaceuticals Plc - Product / Service
• Exhibits137: Jazz Pharmaceuticals Plc - Key news
• Exhibits138: Jazz Pharmaceuticals Plc - Key offerings
• Exhibits139: Les Laboratoires Servier SAS - Overview
• Exhibits140: Les Laboratoires Servier SAS - Business segments
• Exhibits141: Les Laboratoires Servier SAS - Key offerings
• Exhibits142: Les Laboratoires Servier SAS - Segment focus
• Exhibits143: Neurim Pharmaceuticals Ltd. - Overview
• Exhibits144: Neurim Pharmaceuticals Ltd. - Product / Service
• Exhibits145: Neurim Pharmaceuticals Ltd. - Key offerings
• Exhibits146: Novartis AG - Overview
• Exhibits147: Novartis AG - Business segments
• Exhibits148: Novartis AG - Key offerings
• Exhibits149: Novartis AG - Segment focus
• Exhibits150: Oryzon Genomics SA - Overview
• Exhibits151: Oryzon Genomics SA - Product / Service
• Exhibits152: Oryzon Genomics SA - Key offerings
• Exhibits153: Otsuka Holdings Co. Ltd. - Overview
• Exhibits154: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits155: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits156: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits157: Q BioMed Inc. - Overview
• Exhibits158: Q BioMed Inc. - Product / Service
• Exhibits159: Q BioMed Inc. - Key offerings
• Exhibits160: Scioto Biosciences Inc. - Overview
• Exhibits161: Scioto Biosciences Inc. - Product / Service
• Exhibits162: Scioto Biosciences Inc. - Key offerings
• Exhibits163: Spectrum Pharmaceuticals Inc. - Overview
• Exhibits164: Spectrum Pharmaceuticals Inc. - Product / Service
• Exhibits165: Spectrum Pharmaceuticals Inc. - Key offerings
• Exhibits166: Stalicla SA - Overview
• Exhibits167: Stalicla SA - Product / Service
• Exhibits168: Stalicla SA - Key offerings
• Exhibits169: Yamo Pharmaceuticals LLC - Overview
• Exhibits170: Yamo Pharmaceuticals LLC - Product / Service
• Exhibits171: Yamo Pharmaceuticals LLC - Key offerings
• Exhibits172: Zynerba Pharmaceuticals Inc. - Overview
• Exhibits173: Zynerba Pharmaceuticals Inc. - Product / Service
• Exhibits174: Zynerba Pharmaceuticals Inc. - Key offerings
• Exhibits175: Inclusions checklist
• Exhibits176: Exclusions checklist
• Exhibits177: Currency conversion rates for US$
• Exhibits178: Research methodology
• Exhibits179: Validation techniques employed for market sizing
• Exhibits180: Information sources
• Exhibits181: List of abbreviations

The autism spectrum disorder therapeutics market is forecasted to grow by USD 772.65 mn during 2022-2027, accelerating at a CAGR of 7.2% during the forecast period. The report on the autism spectrum disorder therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of ASD, growing number of public-private partnerships, and growing awareness about autism spectrum disorders.

Technavio's autism spectrum disorder therapeutics market is segmented as below:

By Distribution Channel

• Retail pharmacy
• Hospital pharmacy
• Online pharmacy

By Type

• Stimulants
• Selective serotonin reuptake inhibitors
• Antipsychotic drugs
• Sleep medications
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing interest in personalized medicine for treatment of ASD as one of the prime reasons driving the autism spectrum disorder therapeutics market growth during the next few years. Also, growing use of digital therapeutics and rise in exploration of enzyme replacement therapy (ERT) for ASD will lead to sizable demand in the market.

The report on the autism spectrum disorder therapeutics market covers the following areas:

• Autism spectrum disorder therapeutics market sizing
• Autism spectrum disorder therapeutics market forecast
• Autism spectrum disorder therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autism spectrum disorder therapeutics market vendors that include AutismSTEP, Bristol Myers Squibb Co., CureMark LLC, F. Hoffmann La Roche Ltd., Fraser, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Les Laboratoires Servier SAS, Neurim Pharmaceuticals Ltd., Novartis AG, Oryzon Genomics SA, Otsuka Holdings Co. Ltd., PaxMedica Inc., Q BioMed Inc., Scioto Biosciences Inc., Spectrum Pharmaceuticals Inc., Stalicla SA, Travere Therapeutics Inc., Yamo Pharmaceuticals LLC, and Zynerba Pharmaceuticals Inc.. Also, the autism spectrum disorder therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global autism spectrum disorder therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global autism spectrum disorder therapeutics market 2017 - 2021 ($ million)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Retail pharmacy - Market size and forecast 2022-2027
• Exhibit 34: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• 6.4 Hospital pharmacy - Market size and forecast 2022-2027
• Exhibit 38: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• 6.5 Online pharmacy - Market size and forecast 2022-2027
• Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ million)
• Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Stimulants - Market size and forecast 2022-2027
• Exhibit 52: Chart on Stimulants - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Stimulants - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Stimulants - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Stimulants - Year-over-year growth 2022-2027 (%)
• 7.4 Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027
• Exhibit 56: Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
• 7.5 Antipsychotic drugs - Market size and forecast 2022-2027
• Exhibit 60: Chart on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
• 7.6 Sleep medications - Market size and forecast 2022-2027
• Exhibit 64: Chart on Sleep medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Sleep medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Sleep medications - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Sleep medications - Year-over-year growth 2022-2027 (%)
• 7.7 Others - Market size and forecast 2022-2027
• Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.8 Market opportunity by Type
• Exhibit 72: Market opportunity by Type ($ million)
• Exhibit 73: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 115: Market opportunity By Geographical Landscape ($ million)
• Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Bristol Myers Squibb Co.
• Exhibit 123: Bristol Myers Squibb Co. - Overview
• Exhibit 124: Bristol Myers Squibb Co. - Product / Service
• Exhibit 125: Bristol Myers Squibb Co. - Key news
• Exhibit 126: Bristol Myers Squibb Co. - Key offerings
• 12.4 CureMark LLC
• Exhibit 127: CureMark LLC - Overview
• Exhibit 128: CureMark LLC - Product / Service
• Exhibit 129: CureMark LLC - Key offerings
• 12.5 F. Hoffmann La Roche Ltd.
• Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
• 12.6 Jazz Pharmaceuticals Plc
• Exhibit 135: Jazz Pharmaceuticals Plc - Overview
• Exhibit 136: Jazz Pharmaceuticals Plc - Product / Service
• Exhibit 137: Jazz Pharmaceuticals Plc - Key news
• Exhibit 138: Jazz Pharmaceuticals Plc - Key offerings
• 12.7 Les Laboratoires Servier SAS
• Exhibit 139: Les Laboratoires Servier SAS - Overview
• Exhibit 140: Les Laboratoires Servier SAS - Business segments
• Exhibit 141: Les Laboratoires Servier SAS - Key offerings
• Exhibit 142: Les Laboratoires Servier SAS - Segment focus
• 12.8 Neurim Pharmaceuticals Ltd.
• Exhibit 143: Neurim Pharmaceuticals Ltd. - Overview
• Exhibit 144: Neurim Pharmaceuticals Ltd. - Product / Service
• Exhibit 145: Neurim Pharmaceuticals Ltd. - Key offerings
• 12.9 Novartis AG
• Exhibit 146: Novartis AG - Overview
• Exhibit 147: Novartis AG - Business segments
• Exhibit 148: Novartis AG - Key offerings
• Exhibit 149: Novartis AG - Segment focus
• 12.10 Oryzon Genomics SA
• Exhibit 150: Oryzon Genomics SA - Overview
• Exhibit 151: Oryzon Genomics SA - Product / Service
• Exhibit 152: Oryzon Genomics SA - Key offerings
• 12.11 Otsuka Holdings Co. Ltd.
• Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus
• 12.12 Q BioMed Inc.
• Exhibit 157: Q BioMed Inc. - Overview
• Exhibit 158: Q BioMed Inc. - Product / Service
• Exhibit 159: Q BioMed Inc. - Key offerings
• 12.13 Scioto Biosciences Inc.
• Exhibit 160: Scioto Biosciences Inc. - Overview
• Exhibit 161: Scioto Biosciences Inc. - Product / Service
• Exhibit 162: Scioto Biosciences Inc. - Key offerings
• 12.14 Spectrum Pharmaceuticals Inc.
• Exhibit 163: Spectrum Pharmaceuticals Inc. - Overview
• Exhibit 164: Spectrum Pharmaceuticals Inc. - Product / Service
• Exhibit 165: Spectrum Pharmaceuticals Inc. - Key offerings
• 12.15 Stalicla SA
• Exhibit 166: Stalicla SA - Overview
• Exhibit 167: Stalicla SA - Product / Service
• Exhibit 168: Stalicla SA - Key offerings
• 12.16 Yamo Pharmaceuticals LLC
• Exhibit 169: Yamo Pharmaceuticals LLC - Overview
• Exhibit 170: Yamo Pharmaceuticals LLC - Product / Service
• Exhibit 171: Yamo Pharmaceuticals LLC - Key offerings
• 12.17 Zynerba Pharmaceuticals Inc.
• Exhibit 172: Zynerba Pharmaceuticals Inc. - Overview
• Exhibit 173: Zynerba Pharmaceuticals Inc. - Product / Service
• Exhibit 174: Zynerba Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 175: Inclusions checklist
• Exhibit 176: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 177: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 178: Research methodology
• Exhibit 179: Validation techniques employed for market sizing
• Exhibit 180: Information sources
• 13.5 List of abbreviations
• Exhibit 181: List of abbreviations